Jeffrey Wade has extensive experience in the biotechnology and pharmaceutical sectors, currently serving as President and Chief Operating Officer of Lexicon Pharmaceuticals, Inc. since July 2024, after holding various senior roles within the company since 1999, including President and Chief Financial Officer. Prior to joining Lexicon, Jeffrey Wade was a Partner at Andrews Kurth LLP, where representation focused on corporate finance and securities transactions for clients in biotechnology, information technology, and energy industries. Jeffrey Wade earned a JD in Law and a BA in Plan II from The University of Texas at Austin.
Sign up to view 0 direct reports
Get started